Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Assets (2019 - 2025)

Outset Medical (OM) has disclosed Assets for 7 consecutive years, with $264.5 million as the latest value for Q4 2025.

  • Quarterly Assets fell 4.1% to $264.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $264.5 million through Dec 2025, down 4.1% year-over-year, with the annual reading at $264.5 million for FY2025, 4.1% down from the prior year.
  • Assets for Q4 2025 was $264.5 million at Outset Medical, down from $277.3 million in the prior quarter.
  • The five-year high for Assets was $504.8 million in Q2 2021, with the low at $264.5 million in Q4 2025.
  • Average Assets over 5 years is $355.8 million, with a median of $340.3 million recorded in 2023.
  • The sharpest move saw Assets increased 14.77% in 2021, then dropped 25.18% in 2022.
  • Over 5 years, Assets stood at $463.5 million in 2021, then decreased by 13.67% to $400.1 million in 2022, then dropped by 21.57% to $313.8 million in 2023, then dropped by 12.11% to $275.8 million in 2024, then dropped by 4.1% to $264.5 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $264.5 million, $277.3 million, and $288.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.